Beyond Inheritance by Roxanne Khamsi: A Review
An inaugural entry in HD Reads. Roxanne Khamsi’s Beyond Inheritance is the most important popular biology book of 2026 to date, and the foundation text for a way of seeing…
Clonal Hematopoiesis (CHIP): The Cardiovascular Risk Hidden in Your Blood
By age seventy, somewhere between ten and twenty percent of people carry a population of mutated blood stem cells that quietly double their risk of heart disease. The condition has…
Mosaic Aging: Why Your Organs Age at Different Rates, and Why It Matters
A growing body of work argues that the body does not age all at once. It ages in tiles. The pace at which your fastest-aging organ breaks down, not the…
The Hashimoto’s Breakthrough: Somatic Mutations and the New Model of Autoimmune Disease
A landmark Nature study finds that Hashimoto’s thyroiditis is driven in part by acquired somatic mutations that disable the immune system’s brakes. A new model of autoimmune disease is taking…
The Mosaic Body: How Your Cells Are Quietly Mutating, and Why It’s Rewriting Medicine
A new picture of the human body is emerging from the world’s genome sequencers, and it is not the one most of us were taught. We are not single, settled…
Lipoprotein(a): The Hidden Genetic Heart Risk Finally Becoming Treatable in 2026
Lp(a) affects one in five adults worldwide yet has had no targeted therapy for sixty years. In 2026, four Phase 3 trials including HORIZON, OCEAN(a)-Outcomes, ACCLAIM-Lp(a), and a new oral…
The First Longevity Board: How Insilico Medicine Is Using AI to Target the Biology of Aging Itself
Insilico Medicine has formed the industry’s first Longevity Board, chaired by Eli Lilly’s Group VP of Molecular Discovery and featuring Nobel laureate Michael Levitt. Inside the AI strategy, dual-purpose targets,…
Authoring Life by Means of Artificial Biological Intelligence: On the Future of Species by Adrian Woolfson
About ten thousand years ago, a group of Neolithic farmers in the Balsas River Basin of Mexico began writing a genome. They did not know it. The crop they produced,…
Adrian Woolfson and the Battle Over the Future of Genome Writing
Adrian Woolfson helped make genome writing a conversation serious people are having. He also helped make it one of the most charged arguments in modern biomedicine. Part II examines Eric…
How Adrian Woolfson Is Helping Medicine Move From Reading DNA to Writing It
Adrian Woolfson trained under a Nobel laureate at Cambridge, ran global oncology programs at the world’s largest pharmaceutical companies, and led research and development at Sangamo Therapeutics during the first…
